PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2015

Attenuation of traumatic brain injury-induced cognitive impairment in mice by targeting increased cytokine levels with a small molecule experimental therapeutic.

Mouse / TBI

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 25886256 ↗2015Reported benefit

Attenuation of traumatic brain injury-induced cognitive impairment in mice by targeting increased cytokine levels with a small molecule experimental therapeutic.

MouseTBIClosed-head / concussionC57BL/6Jmaleintraperitoneal1, 5 or 10 mg/kg (5 mg/kg used for efficacy studies)single dose at 3 h or 6 h post-injury for cytokine studies; extended paradigm s…

Model: Midline closed head injury (diffuse traumatic brain injury) using a stereotaxic electromagnetic impactor, 5.0 mm steel tip, velocity 5.0 m/s, dwell time 100 ms, impact depth 1.0 mm at ML 0.0 mm, AP -1.5 mm

A single 5 mg/kg dose at 3 h or 6 h post-injury reduced cortical IL-1beta at the 9 h peak by 58 to 63%, with dose-dependent suppression significant at 5 and 10 mg/kg and no effect on CCL2. Extended dosing (3 h, 6 h then daily for 7 days) rescued radial arm water maze performance and reduced IBA1, C…

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.